期刊文献+

甘精胰岛素与中效胰岛素治疗2型糖尿病患者时血糖漂移和低血糖发生率对比分析 被引量:1

The Study of Glycemia Variability and Hypoglycemic Incidence in Type 2 Diabetes Mellitus Cured with NPH and Glargine
原文传递
导出
摘要 目的用动态血糖监测方法评价两种基础胰岛素治疗2型糖尿病(T2DM)时血糖漂移和低血糖发生率的差异。方法分别使用每日1次甘精胰岛素(GL)和每日2次中效胰岛素(NPH)治疗两组T2DM患者,采用动态血糖检测的方法,评价两组患者血糖漂移和低血糖发生率的差异。结果 GL组血糖漂移小于NPH组,差异有统计学意义(P<0.05),低血糖事件,GL组低于NPH组,差异有统计学意义(P<0.05)。结论 GL和NPH治疗T2DM,在空腹血糖控制达标时,GL组血糖漂移度及低血糖发生率较低。 Objective To compare the degree of glycemia variability(GV) and hypoglycemic incidence by dynamic glucose monitoring in type 2 diabetes mellitus (T2DM) cured with NPH and Glargine. Methods Two groups T2DM were treated with NPH (bid) and Glargine(qd). To analyze the difference of GV and hypoglycemic incidence by dynamic glucose monitoring. Results GV of glargine group was less than NPH group(P〈0.05) ,and hypoglyeemic incidence of glargine group was lower than NPH group(P〈0.05). Conclusion GV and hypoglycemic incidence were lower than NPH group.
出处 《慢性病学杂志》 2010年第9期1021-1022,共2页 Chronic Pathematology Journal
关键词 胰岛素/治疗应用 糖尿病 2型/药物疗法 低血糖症/并发症 血糖/代谢 Insulin/therapeutic use Diabetes Mellitus, Type 2/drug therapy Hypoglycemia/complications Blood Glucose/metabolism
  • 相关文献

参考文献5

二级参考文献20

  • 1喻明,周健,项坤三,陆惠娟,马晓静,陆蔚.动态监测糖耐量正常者血糖水平的漂移变化[J].中华医学杂志,2004,84(21):1788-1790. 被引量:50
  • 2周健,喻明,贾伟平,李青,李鸣,马晓静,陆蔚,项坤三.应用动态血糖监测系统评估2型糖尿病患者日内及日间血糖波动幅度[J].中华内分泌代谢杂志,2006,22(3):286-288. 被引量:177
  • 3Wenthoh IME, Kulik W, Michels RP, et al. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia ,2008,51 : 183-190.
  • 4Marfella R,Barbieri M, Grella R,et al. Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations. J Diabetes Complications ,2009, [ Epub ahead of print].
  • 5Heine RJ, Van Gaal LF, Johns D, et al. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes. Ann Intern Med,2005 ,143 :559-569.
  • 6Kohnert KD, Auqstein P, Zander E, et al. Glycemic variability strongly correlates with postprandial β-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglyeemie agents. Diabetes Care,2009, [ Epub ahead of print].
  • 7Lachin JM,Genuth S, Nathan DM, et al. Effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trial-Revisited. Diabetes,2008,57:995-1001.
  • 8Sassa M, Yamada Y, Hosokawa M, et al. Glycemic instability in type 1 diabetic patients:Possible role of ketosis or ketoacidosis at onset of diabetes. Diabetes Res Clin Pract,2008,81 : 190-195.
  • 9Zeymer U, Schwarzmaier-D'assie A, Petzinna D, et al. STOP-NID- DM Trial Research Group. Effect of acarbose treatment on the risk of silent myocardial infarction in patients with impaired glucose tolerance:results of the randomized STOP-NIDDM trial electrocardiography substudy. Eur J Cardiovasc Prey Rehabil,2004,11 : 412-415.
  • 10Esposito K, Giugliano D, Nappo F,et al. Regression of carotid atherosclerosis by control of postprandial hyperglycaemia in type 2 diabetes mellitus. Circulation ,2004,110:214-219.

共引文献41

同被引文献18

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部